Skip to main content

Celebrated architect Art Gensler ’58 dies at 85

Arthur Gensler Jr., B.Arch. ’58, a global architect, entrepreneur and founder of a practice that became one of the largest, most successful firms in the industry, died May 10.

Grants to improve access to care for NYC blood cancer patients

A Weill Cornell Medicine research team will receive $1.3 million over five years to address socioeconomic and racial disparities and increase access to clinical trials for underserved patients with blood cancers living in Brooklyn and Queens.

Africana Library exhibit explores MLK’s labor activism

Exhibit features MLK's ties to labor movement 

Around Cornell

Hanson, Grafstein elected to arts and sciences academy

Maureen Hanson, professor of molecular biology and genetics, and Bernice Grafstein, professor of neuroscience at Weill Cornell Medicine, have been elected to the American Academy of Arts and Sciences.

Vaccinated pregnant women pass antibodies to their babies

Women who receive COVID-19 mRNA vaccines produced by Pfizer-BioNTech or Moderna while in their third trimester of pregnancy generate a strong immune response and pass protective antibodies to their babies.

Study reveals a cause of heart damage in COVID-19 patients

In the study, researchers at Weill Cornell Medicine and their colleagues also identified new potential treatments for COVID-19 patients and described a model for drug screening.

Weill Cornell Medicine addresses vaccine hesitancy, access

Diversity leaders at Weill Cornell Medicine have launched ambitious community vaccination and education efforts, with the goal of improving uptake and helping those who are reluctant to get the vaccine.

Center for Virtual Care expands digital health training

The center’s latest offering is a two-week online course, developed with eCornell, that provides strategies practitioners can use when caring for their patients remotely.

New technique provides map of lung pathology in COVID-19

A team led by investigators at Weill Cornell Medicine and NewYork-Presbyterian has used advanced technology and analytics to map the cellular landscape of diseased lung tissue in severe COVID-19 and other infectious lung diseases.